🇺🇸 FDA
Patent

US 10420833

Combinatorial platform for the display of surface adjuvants and antigens

granted A61KA61K2039/522A61K2039/5252

Quick answer

US patent 10420833 (Combinatorial platform for the display of surface adjuvants and antigens) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/522, A61K2039/5252, A61K2039/55572, A61K2039/55583